David Hessl
Zero to Three(US)University of California Davis Medical Center(US)UC Davis Health(US)University of California, Davis(US)
Publications by Year
Research Areas
Genetics and Neurodevelopmental Disorders, Autism Spectrum Disorder Research, Congenital heart defects research, Family and Disability Support Research, Mitochondrial Function and Pathology
Most-Cited Works
- → A pilot open label, single dose trial of fenobam in adults with fragile X syndrome(2009)410 cited
- → Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome(2017)343 cited
- → Autism Spectrum Disorders and Attention-Deficit/Hyperactivity Disorder in Boys with the Fragile X Premutation(2006)326 cited
- → Fragile-X–Associated Tremor/Ataxia Syndrome (FXTAS) in Females with the FMR1 Premutation(2004)325 cited
- → Effects of STX209 (Arbaclofen) on Neurobehavioral Function in Children and Adults with Fragile X Syndrome: A Randomized, Controlled, Phase 2 Trial(2012)324 cited
- → Diurnal salivary cortisol in pediatric posttraumatic stress disorder(2002)324 cited